Global Acute Spinal Cord Injury Market – Industry Trends and Forecast to 2030

Global Acute Spinal Cord Injury Market, By Type (Complete Spinal Cord Injury, Incomplete Spinal Cord Injury), Treatment Type (Corticosteroid, Surgery, Spinal Traction), End User (Hospitals, Trauma Centers) - Industry Trends and Forecast to 2030.

Acute Spinal Cord Injury Market Analysis and Size

The rise in incidences of spinal injuries and lower back pain across the globe acts as one of the major factors driving the growth of acute spinal cord injury market. The increase in demand for specific treatment for curing for symptoms observed in acute spinal cord injuries are muscle weakness, breathing problems, loss of voluntary muscle movement, and loss of sensation in body parts, and continuous advancements in the healthcare sector accelerate the market growth. The surge in accidents caused by playing outdoor sports linked to the injuries demanding efficient treatment, and availability of various imaging test such as imaging tests consist of x-ray, computed tomography (CT) scan and magnetic resonance imaging (MRI) further influence the market. Additionally, improved healthcare infrastructure, growth in awareness, increase in the population and surge in the healthcare spending positively affects the acute spinal cord injury market.                                

Data Bridge Market Research analyses that the acute spinal cord injury market which was USD 6,826.4 million in 2023, would rocket up to USD 9,892.5 million by 2030, and is expected to undergo a CAGR of 5.4% during the forecast period. This indicates that the market value. “Incomplete spinal injury” dominates the type segment of the acute spinal cord injury market owing to the increased number of road accidents. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Acute Spinal Cord Injury Market Scope and Segmentation

Market Definition

The global acute spinal cord injury market refers to the market for medical products and treatments aimed at managing and treating acute spinal cord injuries (SCI). Acute SCI refers to a sudden and severe injury to the spinal cord, resulting in a range of neurological impairments and functional deficits. The market encompasses pharmaceuticals, medical devices, surgical interventions, and rehabilitation therapies that are designed to address the immediate consequences of a spinal cord injury and promote recovery and functional improvement.

Acute Spinal Cord Injury Market Dynamics

Drivers

• Increasing Incidence of Spinal Cord Injuries

The rising incidence of traumatic accidents, sports-related injuries, and falls has led to a higher number of acute spinal cord injury cases globally. This factor drives the demand for effective treatment options and medical interventions.

• Growing Aging population

The globe has a large aging population, and older adults are more prone to back pain and spinal injuuries. As the population continues to age, the acute spinal cord injury is expected to grow significantly.

• Favourable Government Initiatives and Funding

Governments and healthcare organizations worldwide have recognized the importance of spinal cord injury research and rehabilitation. They provide funding support and promote initiatives to enhance treatment options, rehabilitation services, and accessibility to medical care for SCI patients.  

Opportunities

• Advancements in Neuroprotection and Neuroregeneration Therapies

There is a significant opportunity for the development of novel neuroprotective and neuroregenerative therapies for acute SCI. Research into stem cell transplantation, gene therapy, growth factors, and other regenerative approaches holds promise for promoting tissue repair and functional recovery in patients with SCI.

Restraints/Challenges

• Limited Healthcare Infrastructure

In many regions, particularly in developing countries, the healthcare infrastructure may be inadequate to address the complex needs of individuals with acute SCI. Lack of specialized healthcare facilities, rehabilitation centers, and trained healthcare professionals can hinder timely and effective management of SCI cases.

This acute spinal cord injury market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Acute Spinal Cord Injury market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2022, Amneal Pharmaceuticals, Inc., announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (“FDA”) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.
• In August 2021, Novartis AG  announced that the U.S. Food and Drug Administration (FDA) has determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, thereby lifting the partial clinical trial hold initiated in October 2019.

Global Acute Spinal Cord Injury Market Scope

The acute spinal cord injury market is segmented on the basis of type, treatment type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury

Treatment Type

• Corticosteroid
• Surgery
• Spinal Traction

End User

• Hospital
• Trauma Centers

Acute Spinal Cord Injury Market Regional Analysis/Insights

The acute spinal cord injury market is analysed and market size insights and trends are provided by country, type, treatment type, and end user as referenced above.

The countries covered in the acute spinal cord injury market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

North America dominates the acute spinal cord injury market because of the increase in the awareness and advanced technologies within the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to the presence of emerging economies such as China, India, Brazil and an increase in developmental investment in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The acute spinal cord injury market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Acute Spinal Cord Injury market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Acute Spinal Cord Injury market. The data is available for historic period 2010-2020.

Competitive Landscape and Acute Spinal Cord Injury Market Share Analysis

The acute spinal cord injury market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to acute spinal cord injury market.

Some of the major players operating in the acute spinal cord injury market are:

• Novartis AG
• Tenax Therapeutics.
• Accure Pharma.
• Acorda Therapeutics, Inc.
• Asterias Biotherapeutics
• ReNetX Bio.
• BioArctic AB
• BioTime, Inc.
• InVivo Therapeutics
• Kringle Pharma, Inc.
• BioAxone, AO Foundation
• Pfizer Inc.
• Pharmicell Co. Ltd.
• Vertex Pharmaceuticals Inc.
• Axoltis
• K-STEMCELL Co., Ltd.,
• WAKAYAMA MEDICAL UNIVERSITY